GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $187,000 | +49.6% | 13,130 | -56.7% | 0.01% | -28.6% |
Q1 2020 | $125,000 | +56.2% | 30,301 | +169.1% | 0.01% | +250.0% |
Q1 2019 | $80,000 | 0.0% | 11,262 | -31.7% | 0.00% | 0.0% |
Q4 2018 | $80,000 | +37.9% | 16,500 | +19.4% | 0.00% | +100.0% |
Q4 2017 | $58,000 | – | 13,818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |